GLP-1 Receptor Agonist Exposure Linked to Neovascular AMD in Patients With Diabetes
More than twofold increased risk seen for nAMD development in unadjusted and adjusted models
2021 to 2023 Saw Rise in Cannabis Use by Older Adults
Notable shifts seen among those with higher income and certain clinical conditions
Cardiometabolic Risk Factors Account for More Than One-Third of Dementia Risk
Hypertension, ischemic heart disease, and chronic heart failure have the greatest attributable fractions
Concurrent Hypertension + Type 2 Diabetes Predict High Mortality Risk
Higher all-cause and cardiovascular mortality predicted with concurrent hypertension and type 2 diabetes
High Transepidermal Water Loss in Diabetic Foot Ulcer Tied to Recurrence
High TEWL at center of recently healed diabetic foot ulcer linked to increased odds of recurrence
Lamivudine Improves Visual Acuity in Center-Involved Diabetic Macular Edema
Best corrected visual acuity improved 9.8 letters with lamivudine after four weeks, decreased 1.8 letters with placebo
Prevalence of Disability Up Over Twofold for Current Smokers
Disability prevalence 14.1 percent for current smokers, 6.8 percent for never smokers, and 12.6 percent for former smokers
Total Number of Excess Deaths >14.7 Million in U.S. in 1980 to 2023
U.S. mortality rose rapidly in 2020 and 2021, then declined in 2022 and 2023, remaining higher than in 2019
RFK Jr. May Block Government Scientists From Publishing in Top Medical Journals
ASCO: GLP-1 Receptor Agonists May Reduce Risk for Obesity-Related Cancer, All-Cause Death
Protective association seen between GLP-1 receptor agonist use and colon and rectal cancers in adults with obesity and diabetes
